Search company, investor...

Predict your next investment

Corporation

About McGraw-Hill Companies

Note: This investor/acquirer profile is no longer active. In 2012, The McGraw-Hill Companies split into McGraw Hill Education and McGraw Hill Financial. All prior acquisitions and investments will be found on those respective profiles. Founded in 1888, The McGraw-Hill Companies was a global financial information and education company. Its brands included Standard & Poor's Ratings Services, S&P Dow Jones Indices, S&P Capital IQ, McGraw-Hill Education, Platts energy information services and J.D. Power and Associates.

Headquarters Location

1221 Ave. of the Americas

New York, New York, 10020,

United States

Want to inform investors similar to McGraw-Hill Companies about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest McGraw-Hill Companies News

How is Information from ABC–VED–FNS Matrix Analysis Used to Improve Operational Efficiency of Pharmaceuticals Inventory Management? A Cross-Sectional Case Analysis

Jun 24, 2021

Source Population Study Population The study population included all RDF commodities distributed by Jimma hub, the HCMIS, and the bin-cards used to track RDF commodities transactions in the 2019/2020 fiscal year (between August 2019 and June 2020). In Ethiopia, annual stock verification is usually done in July. As a result, the study took 11 months of transaction data into account in the fiscal year. Study Units All RDF commodities handled by the EPSA Jimma hub were included in the study. The analysis takes into account RDF commodities issued (distributed) to service delivery points in the 2019/20 fiscal year (FY). We gave all RDF commodities the same opportunity to take part in this study. Inclusion and Exclusion Criteria For the 2019/20 FY transactions, analyses of RDF transactions data from the electronic HCMIS and bin-cards were performed. Due to their capital cost nature, we excluded sales transactions involving medical equipment. Data Collection Procedure and Instrument The annual sales list with respective total quantity, unit price, frequency of issue transaction counts, and days out of stock in 2019/20 FY were collected from the electronic HCMIS and stock-keeping records (bin cards). The EPSA-Jimma hub’s pharmaceutical report and requisition list was used to generate VED data. The list is the result of a series of stakeholder consultations with relevant public health experts. A structured data abstraction format in a Microsoft office Excel 2013 was adapted from management science for Health to collect the required data. 23 Data Analysis Microsoft Excel was used to compile the data. The descriptive analysis was carried out with the help of the Excel statistical functions. The procedures undertaken in our study to categorize ABC–VED–FNS analysis and matrix involve the following steps: Step 1: The ABC classification was computed based on the total annual sales values. The total price (multiplying total quantity by unit price) was calculated for each item and rearranged in descending order by total value. We computed the percentage of the total cost, the cumulative percentage by costs and items. The cut-off points for class A, B, and C were determined based on the Pareto principle. Step 2: We inserted the VED category of each item in the product sales list. Step 3: The ABC and VED analyses were combined by cross-tabulation to get an ABC/VED matrix. From the resulting matrix, three categories were framed (I, II, and III). Category I consists of products belonging to either the A or V groups (AV, AE, AD, BV, and CV subcategories) for focused managerial control since these items are expensive or vital; category II consists of the BE, BD, and CE subcategories, and category III consists of the remaining items in the CD subcategory. Step 4: In FNS Analysis, we consider the number of issue transactions, annual sales quantity, and the average monthly consumption (AMC) for each item. The AMC was computed by dividing the total quantity sold by the number of months the item is available in the warehouse for the 2019/20 FY. The lists of items were sorted in a descending order based on the AMC values. Then, we computed the 15th, 30th, and 45th percentiles from the AMC data. 28 The highest AMC items in the inventory (issue transaction counts greater than 200 and AMC values greater than the 15th percentile) are classified as Fast-moving items, items which are moderately issued (AMC values between 15th and 45th percentile and issue counts between 50–199) to customers denoted as Normal-moving items, and the remaining items with the lowest number of issue counts (< 50 issue counts in a year) and the AMC values less than the 45th percentile were denoted as Slow-moving products. Step 5: The ABC–VED–FNS matrix analysis was framed by concatenating the ABC, VED, and FNS analysis. The resulting 27 combinations (3*3*3) are grouped into three (3) major categories. Category I comprises of items belonging to category “A” or “V” with “FNS” matrices; the BE, BD, and CE with “FNS” matrices constituted category II, and the other items in the CDF, CDN and CDS matrix constituted category-III. In these matrices, the first alphabet represents its place in the ABC analysis, the second alphabet stands for its place in the VED analysis, while the third alphabet stands for FNS analysis. The results were presented using tables and charts. Results ABC Analysis The result of the analysis indicated that 393 items were transacted in the 2019/20 FY to the customers. The findings ( Figure 1 ) shows that 58 (14.8%) items were found to be Class A, 78 (19.8%) items belong to Class B, and 257 (65.4%) items belong to Class C. The analysis indicated that only 58 (14.8%) items accounted for 79.9% of ASV (A-class items) whereas, 257 (65.4%) items accounted for only 6% of ASV (C-class items). Figure 1 ABC analysis by cumulative curve, 2020 (N = 393 items). VED Analysis The findings in Table 1 revealed that 165 (42%) of the items were Vital, 194 (49%) items classified as Essential and only 34 (9%) of the items classified as the desirable items. Interestingly, vital items constituted most of the annual sales value (73%) and desirable items only 2% of the annual sales value. Table 1 ABC, and VED Analysis and ABC-VED Matrix Analysis of the EPSA Pharmaceuticals (N = 393) ABC-VED Matrix ABC and VED analyses of 393 items revealed that 36 (9%), 42 (11%), and 87 (22%) of AV, BV, and CV category items account for 63%, 8%, and 2% annual sales value respectively. There was no desirable (D) commodity that belongs to Class A. The study explored three categories that would require different inventory control techniques. Category I Commodities (AV, AE, BV and CV) making a total of 187 (47.58%) items amounted to 90% ASV. The category II Commodities (BE, CE and BD) with a total of 178 (45.29%) items accounted for 9% ASV. The least priority items (Category III) comprises CD with 28 (7.13%) items accounted for only 1% ASV ( Table 1 ). FNS Analysis We undertake FNS analysis based on the number of issue transactions and the average monthly consumption for each item. We employed the 15th and 45th percentiles to determine the cut-off points. The analyses revealed 60 (15.30%) products were classified as Fast-moving items accounted for 73.1% in ASV in the FY. One hundred-twelve (28.5%) items were Normal-moving items amounted to 20.30% ASV in the 2019/20 FY. About 221 (56.20%) items were Slow-moving items with an ASV of 6.6% ( Table 2 ). Table 2 FNS Analysis of Pharmaceuticals in the Study Area, 2020 (N = 393) ABC–VED–FNS Matrix Analyses Having concatenated the three different inventory classification techniques (ABC, VED, and FNS classification) to generate a coupled matrix, the 27 different combinations were grouped into three main categories (I, II, and III). From the resulting matrix, category I consisted of 12 sub-groups (AVF, AVN, AVS, AEF, AEN, AES, BVF, BVN, BVS, CVF, CVN, and CVS) with 187 (47.6%) items whereas 28 (7.13%) items in the CDN and CDS matrix constituted category-III ( Table 3 ). Table 3 ABC, VED, and FNS Analysis and ABC–VED–FNS Matrix Analysis in the Study Area (N = 393) Table 4 shows that the maximum issue frequency in a fiscal year is 838 times. The inventory managers should pay particular attention for managing the 29 AVF inventories storage, order size, and movement to ensuring availability and minimizing wastage. Table 4 Top-Ten “AVF” Pharmaceuticals from ABC–VED–FNS Matrix Analysis in the Study Area (N = 393) Discussions Service-providing organizations should maintain an appropriate level of inventory to satisfy customers’ requests while reducing associated costs. Selective inventory control techniques and classification are paramount for efficient utilization and management of pharmaceutical inventory. In this study, we focused on the ABC, VED, and FNS analyses and matrix. The ABC analysis provides a mechanism for identifying items that have a significant impact on overall inventory cost. The findings in the ABC analysis revealed 58 (14.8%) class A-items that represent 79.9% of ASV; 78 (19.8%) class B-items that represent a further 14.2% of ASV, and 257 (65.4%) items with only 5.9% of ASV constituted category C-items. Our findings are consistent with previous studies conducted in India, Turkey, and Ethiopia, which found that class A-items contributed to 72.9%, 80%, and 80.1% of annual drug expenditures, respectively. 17 , 29 , 30 This analysis would enable managers to focus more on class A-items with tight control and no inventory discrepancy, while class C-items would have very little control. As a result, the analysis can assist logistics managers in developing inventory count policies (class A-items can be counted once every week, B-items biweekly, and C-items monthly), and stocking levels (arrange more frequent purchases or delivery of smaller quantities of class A-items). The VED analysis of this study indicates 165 (42%) vital items, 194 (49%) essential items and 34 (9%) desirable items. Interestingly, vital items constituted most (73%) of the ASV and desirable items only 2% of the ASV. This implies that the agency in consultations with stakeholders and relevant experts from health facilities tried the best on ensuring that most of the budget is allocated for the vital and essential items rather than the desirable ones. In comparison to other studies conducted in Baghdad, India, and Ethiopia, the proportion of vital items and ASV was very high. 14 , 21 , 29 According to the findings, V–items amounted to 18.1%, 19.49%, and 35.1% of total item expenditure in their studies. The difference could be that the agency manages a compiled list of medications from customers with varied levels and preferences. Cross-tabulation of the ABC with VED provides a critical analysis of each category of items according to cost significance and criticality since equal attention cannot be devoted to the entire inventory. The analysis revealed that 187 (47.58%), 178 (45.29%), and 28 (7.13%) of category I, II, and III items account for 90%, 9%, and 1% ASV as per the orders. However, studies conducted by Mathew et al, 2016; Sushil and Chakravarty, 2014 showed variations with this study. 14 , 20 This could be the difference in the study setting, as well as different institutions have varying service profiles depending on the specialty services available. The 187 (47.58%) items in category I should be given high priority by top management. The operational efficiency of the warehouses can be substantially improved by focusing on 47.58% of items (amounted to 90% ASV). Directing staff activities, accurate demand forecasting, safety stock levels, and consumption trends should be monitored continuously for these groups of items. Category II items (178, 45.29%) accounted for 9% of the ASV. These items should be ordered once or twice a year and should be monitored and controlled on a periodic basis. Category III items (28, 7.13%) contained 1% of the ASV. These items should also be ordered once or twice a year, thereby reducing ordering cost and carrying cost without tying up substantial capital. The analyses revealed 60 (15.30%) products were classified as Fast-moving F items accounted for the greatest proportion (73.10%) of total value in the budget year. This result also showed the maximum issue frequency of 838 times per year; most of them had an issue frequency above 200 times per year. This result is lower than that of Manivel, Ranganathan, 2016, and Jobira et al, 2020, who uncovered that 46.03% and 35.3% of F-class items accounted for 56.30% and 78.4% of total value, respectively. 24 , 29 The variations can be attributed to the nature and numbers of items analyzed and differences in the study setting and methodology employed as pharmaceutical needs vary by situation and country. To minimize the time and labor cost of put-away, picking and packing, and effective use of material handling equipment, the F items should be placed nearest to the order marshalling and dispatch areas in the warehouse. In the current work, 112 (28.50%), and 221 (56.20%) products were classified as N and S items accounted for 20.30% and 6.60% of ASV in the budget year. This implies the majority of items (56.20%) were in the S category. Slow-moving stocks have come from managing items with diminishing consumer demand, quality defects, regimen shifts, switching to new equipment or technology, holding seldom used medicines (eg, snake venom antiserum, amphotericin B 50mg injection) in case-specific rare events, or stocking of products to provide patients with rare diseases (eg, Amiodarone, L-Asparaginase). As a result, slow-moving items should be studied further to control obsolescence, products with diminishing consumer demand should be tracked in the system, safety stock levels and reorder points should be adjusted downwardly, and these products also require prior planning and flexibility as well as promotions to minimize inventory carrying cost. They should be stored in a warehouse far away from order marshalling and dispatch areas in order to devise an effective inventory policy. Logistics managers and advisors have been challenged with handling hundreds of pharmaceutical items, each with their characteristics, requiring complex and time-consuming inventory control techniques. The combined approach provides results based on total cost, criticality value, and the rate of consumption of products. This study revealed 60 (15.3%) F-items with nine (9) subclasses [AVF =29, AEF = 10, BEF = 10, CVF =4, CEF = 2, CDF = 9, ADF =0, BDF =0, and CDF =0). Thus, the 29 AVF products should be arranged in the warehouse closest to the order marshalling and dispatch area (pick-face area) so that warehouse personnel can inspect, access, pick, track, and deliver the product in a timely manner for order fulfilment. Moreover, 28 (7.13%) items (4 = CDN and 24 = CDS) constituted category-III. Owing to the low stock level, and slow/non-moving nature of these items, they should be redistributed to other hubs, considered disposal ways, or donated to charity to minimize disposal costs. Despite its ability to improve inventory control policies by allowing for the identification of active or dead-stocks for effective inventory management, the ABC-VED-FNS analysis has limitations. Sometimes, organizations may choose to stockpile products with a high risk of shortages or for emergency situations to deal with supply chain disruptions, but this may significantly impact inventory carrying costs as well as its flow. In this particular instance, the ABC-VED-FNS analysis is completely irrelevant. Conclusion and Recommendation Instigating combined inventory control techniques (ABC–VED–FNS) can assist supply chain managers in realizing substantial financial and operational benefits. The ABC-VED-FNS matrix classifies pharmaceuticals based on their cost significance, relative public health value, and average warehouse flow/stay respectively. Implementing the ABC–VED–FNS matrix analysis can help organizations to develop inventory control policies and techniques, narrows down a categories of items requiring greater managerial monitoring and control, prioritizes storage location (pick-face) plan, minimizes the time and labor cost of put-away, picking, and packing, prioritizes products to be reordered or replenished, as well as useful in directing staff activities. Thus, the inventory analysis needs to be adopted as a routine practice for optimal inventory control of pharmaceuticals. Abbreviations ABC, Always Better Control; AMC, Average Monthly Consumption; ASV, Annual Sales Value; EPSA, Ethiopian Pharmaceutical Supply Agency; FNS, Fast-, Normal-, and Slow-moving; FY, Fiscal Year; HCMIS, Health Commodities Management Information System; VED, Vital, Essential, and Desirable. Data Sharing Statement The dataset(s) generated and/or analyzed during the current study are available from the corresponding author on reasonable request. Ethics Approval and Consent to Participate The ethics committee of the Research and Postgraduate Office (RPO), College of Business and Economics, Jimma University (Reference No: RGS/199/2020) provided an ethical clearance letter. Following a debriefing on the study objective, we obtained a formal letter of support from the EPSA Jimma hub. Before beginning data collection, we copied the official support letter to the employees in the hub, which included desired data. After that, in compliance with the RPO, the employees’ informed consent was sought. Acknowledgments Funding Disclosure References 1st ed. McGraw-Hill Companies, Inc; 1998. 2. Kushwaha S, Sohani N, Kumar S. Effectiveness of logistics, distribution & customer satisfaction in courier company. Int J Sci Res Dev. 2017;5(05):1832–1834. 3. The Chartered Institute of Logistics and Transport UK. Glossary of terms and dictionaries; 2019. Available from: https://ciltuk.org.uk/knowledge/knowledge-bank/resources/other-resources/useful-glossaries . Accessed 7. Chopra S, Meindl P. Supply Chain Management: Strategy, Planning, and Operation. 6th ed. Edinburgh Gate: Pearson Education Limited; 2016. 8. Wang M. Logistics capability, supply chain uncertainty and risk, and logistics performance: an Empirical Analysis of the Australian Courier Industry. Int J Innov Manag. 2016;20(07):1650070. 9. Harrison A, Van Hoek RI. Logistics Management and Strategy: Competing Through the Supply Chain. 3rd ed. Harlow, England: Pearson Education LTD.; 2008. 10. Shan H, Li Y, Shi J. Influence of supply chain collaborative innovation on sustainable development of supply chain: a Study on Chinese Enterprises. MDPI Sustain. 2020;12:1–19. doi:10.3390/su12072978 11. Wisner JD, Tan KC, Leong GK. Principles of Supply Chain Management. 3rd ed. Mason, USA: Nelson Education, Ltd.; 2012. 12. Frazelle E. Supply Chain: The Logistics of Supply Chain Management. New York, USA: McGraw-Hill Companies, Inc; 2002. doi:10.1036/0071418172 13. Cohen S, Roussel J. Strategic Supply Chain Management: The 5 Disciplines for Top Performance. 2nd ed. United States of America: McGraw-Hill Companies, Inc.; 2005. doi:10.1036/0071454497 14. Mathew B, Panavila L, Sindhu K, Rajaneesh P, Bharath. V, Doddayya H. A study on inventory management by ABC, VED and ABC-VED Matrix analysis in pharmacy department of a tertiary teaching hospital. Asian J Pharm Health Sci. 2016;6(4):1563–1568. 15. Fitriana I, Gagak R, Satria D, Cahyo D, Setiawan B. Medicine inventory management by ABC-VED analysis in the pharmacy store of veterinary Hospital, Yogyakarta, Indonesia. Asian J Anim Vet Adv. 2018;13(1):85–90. doi:10.3923/ajava.2018.85.90 16. Brindha G. Inventory Management. Int J Innov Res Sci Eng Technol. 2014;3(1):8163–8176. 17. Nigah R, Devnani M, Gupta AK. ABC and VED analysis of the pharmacy store of a Tertiary Care Teaching, Research and Referral Healthcare Institute of India. Young Pharm Manag. 2010;2(2):201. doi:10.4103/0975-1483.63170 18. Blecker T, Kersten W. Operational Excellence in Logistics and Supply Chains: Optimization Methods, Data-Driven Approaches and Security Insights. 3rd ed. Kersten W, Blecker T, Ringle CM, editors. Hamberg: HICL (hicl.org) or at the TUBdok – Publication; 2015. Available from: https://creativecommons.org/licenses/by-sa/4.0/ . Accessed . 19. Santhi G, Karthikeyan K. Recent review article on Pharmaceutical Inventory Models. Int J Pharm Tech Res. 2016;9(5):435–443. 20. Sushil M, Chakravarty BA. ABC-VED analysis of expendable medical stores at a tertiary care hospital. Med J Armed Forces India. 2014;7:24–27. Elseviier. doi:10.1016/j.mjafi.2014.07.002 21. Al-najjar SM, Jawad MK, Saber OA. Application of ABC-VED matrix analysis to control the inventory of a central pharmacy in a public hospital: a Case Study. Int J Sci Res. 2020;9(1):1333–1334. doi:10.21275/ART20204180 22. Abate SM. Assessment of pharmaceuticals inventory management systems for the years (2008, 2009, 2010) using ABC-VEN matrix analysis at Addis Ababa University College of Health Sciences Tikur Anbessa (Black Lion) Specialized Hospital, Advances in Pharmacoepid. Adv Pharmacoepidemiol Drug Saf. 2013;2(3):2012–2013. doi:10.4172/2167-1052.100013 23. Management Science for Health. MDS-3: managing access to medicines and health technologies. Arlington, USA; 2012. 24. Manivel P, Ranganathan R. Prioritized ABC – FSN analysis of inventory management in private and hospital pharmacy followed by questionnaire. Int Res J Pharm. 2016;7(12):111–113. doi:10.7897/2230-8407.0712155 25. Gurmu TG, Ibrahim AJ. Inventory management performance of key essential medicines in health facilities of East Shewa Zone, Oromia Regional State, Ethiopia. Cukurova Med J. 2017;42(2):282–285. doi:10.17826/cutf.322908 26. Ethiopian Pharmaceuticals Supply Agency. Ethiopia: National Survey of the Integrated Pharmaceutical Logistics System (IPLS): AIDSFree, and Pharmaceutical Supply Agency (EPSA). Addis Ababa, Ethiopa; 2019. Accessed

McGraw-Hill Companies Team

1 Team Member

McGraw-Hill Companies has 1 team member, including former Controller, Barbara Hopper.

Name

Work History

Title

Status

Barbara Hopper

Controller

Former

Name

Barbara Hopper

Work History

Title

Controller

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.